Associate Professor, Psychiatry, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Psychiatry
Dr. John M. Hettema, MD
|
|
Give Review
John M. Hettema, MD is an expert in the field of Psychiatry. He studied medicine at Virginia Commonwealth University School of Medicine. John M. Hettema, MD is a published doctor. He has 55 papers published. The most current publication "Testing the effect of season of birth on familial risk for schizophrenia and related disorders." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- The impact of childhood parental loss on risk for mood, anxiety and substance use Disorders in a population-based sample of male twins.
- Obsessive compulsive symptom dimensions and neuroticism: An examination of shared genetic and environmental risk.
- The structure of genetic and environmental risk factors for fears and Phobias.
- Genetic association between RGS1 and internalizing Disorders.
- Parenting and risk for mood, anxiety and substance use Disorders: a study in population-based male twins.
- Genetic association study between RGS2 and Anxiety-related phenotypes.
- Meta-analyses of genome-wide linkage scans of Anxiety-related phenotypes.
- Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR(*)D.
- Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
- Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.
- SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive.
- Pilot multimodal twin imaging study of generalized anxiety Disorder.
- Prioritization and Association Analysis of Murine-Derived Candidate Genes in Anxiety-Spectrum Disorders.
- The AVPR1A Gene and Substance Use Disorders: Association, Replication, and Functional Evidence.
- A genomewide association study of citalopram response in major depressive Disorder-a psychometric approach.
- An association between Epac-1 gene variants and Anxiety and depression in two independent samples.
- Association study of CREB1 with Major Depressive Disorder and related phenotypes.
- Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence.
- Association study between GABA receptor genes and anxiety spectrum Disorders.
- Assessment of generalized anxiety Disorder diagnostic criteria in the National Comorbidity Survey and Virginia Adult Twin Study of Psychiatric and Substance Use Disord...
- Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism.
- Catechol-O-methyltransferase contributes to genetic susceptibility shared among Anxiety spectrum phenotypes.
- Cannabinoid receptor 1 gene association with nicotine dependence.
- Heritability of obsessive-compulsive symptom dimensions.
- What is the genetic relationship between Anxiety and depression?
- The risk of overweight in children and adolescents with Major mental illness.
- The genetic covariation between fear conditioning and self-report fears.
- The nosologic relationship between generalized anxiety Disorder and major depression.
- A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.
- Low extraversion and high neuroticism as indices of genetic and environmental risk for social Phobia, agoraPhobia, and animal Phobia.
- A population-based twin study of the relationship between neuroticism and internalizing Disorders.
- Posttraumatic stress Disorder: clinical features, pathophysiology, and treatment.
- The structure of genetic and environmental risk factors for anxiety Disorders in men and women.
- Genetic and environmental sources of covariation between generalized anxiety Disorder and neuroticism.
- Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized Anxiety.
- A twin study of the genetics of fear conditioning.
- Genome-wide and gene-based association studies of anxiety Disorders in European and african american samples.
- Lack of association between the amiloride-sensitive cation channel 2 (ACCN2) gene and anxiety spectrum Disorders.
- Follow-up association study of novel neuroticism gene MAMDC1.
- Endorsement frequencies and factor structure of DSM-III-R and DSM-IV Generalized Anxiety Disorder symptoms in women: implications for future research, classification, ...
- The impact of generalized anxiety Disorder and stressful life events on risk for major depressive episodes.
- Association between glutamic acid decarboxylase genes and anxiety Disorders, major depression, and neuroticism.
- A whole genome association study of neuroticism using DNA pooling.
- The effects of anxiety, substance use and conduct Disorders on risk of major depressive Disorder.
- A population-based twin study of generalized anxiety Disorder in men and women.
- A review and meta-analysis of the genetic epidemiology of anxiety Disorders.
- Physical similarity and the equal-environment assumption in twin studies of psychiatric Disorders.
- Testing the effect of season of birth on familial risk for schizophrenia and related Disorders.
- A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins.
- Childhood sexual abuse and adult psychiatric and substance use Disorders in women: an epidemiological and cotwin control analysis.
- Advances in molecular genetics of panic Disorder.
- Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety Disorders.
- Co-morbid major depression and generalized anxiety Disorders in the National Comorbidity Survey follow-up.
- Genetic analysis of autonomic reactivity to psychologically Stressful situations.
Schools
Virginia Commonwealth University School Of Medicine
McV Hospital
Procedures Preformed
- Group Psychotherapy
- Psychiatric Evaluation
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Virginia Commonwealth University Health System -
Virginia Commonwealth University School of Medicine
Drug Facts
| NPI NUMBER | 1639259088 | |
| NPPES Provider LastName | HETTEMA | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 232985051 | |
| NPPES Provider State | VA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 722.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639259088 |
| Last Name Of The Provider | HETTEMA |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Franklin F. Boon, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen A. Brosnan, MD |
|
|
Dr. Neena G. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis Petrocelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheila M. Furey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rose M. Gustilo, MD |